XstalBio is a Glasgow-based company specialises in the formulation of biomolecules in the form of particles engineered for advanced drug delivery. The company’s proprietary technology is applicable to proteins, peptides, nucleic acids and vaccines and has the potential to improve therapeutic value, strengthen patent cover for new biological entities and extend product life-cycles.